Unique Wealth Strategies’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-8,202
Closed -$209K 254
2025
Q3
$209K Sell
8,202
-17,479
-68% -$431K 0.08% 201
2025
Q2
$623K Buy
25,681
+4,652
+22% +$108K 0.26% 104
2025
Q1
$533K Sell
21,029
-1,460
-6% -$38.2K 0.24% 117
2024
Q4
$597K Sell
22,489
-13,056
-37% -$354K 0.26% 95
2024
Q3
$1.03M Sell
35,545
-3,491
-9% -$102K 0.43% 57
2024
Q2
$1.08M Hold
39,036
0.51% 47
2024
Q1
$1.08M Buy
39,036
+1,902
+5% +$52.8K 0.53% 47
2023
Q4
$1.07M Buy
+37,134
New +$1.12M 0.71% 36

Other funds holding PFE

Unique Wealth Strategies's PFE Position: Q4 2025 in Review

Unique Wealth Strategies sold out of Pfizer (PFE) in Q4 2025, closing a stake of 8,202 shares — an estimated $209K sold.

Unique Wealth Strategies first reported a position in PFE in Q4 2023 and held it in 8 quarters. The position peaked at $1.08M in Q2 2024. 2,906 funds tracked by Wall St. Rank hold PFE as of Q4 2025.

  • Unique Wealth Strategies reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
  • Unique Wealth Strategies sold 8,202 Pfizer shares in Q4 2025, an estimated $209K.
  • Unique Wealth Strategies first reported a position in Pfizer in Q4 2023 and held it in 8 quarters.
  • Unique Wealth Strategies's Pfizer position peaked at $1.08M in Q2 2024.
  • 2,906 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.

Based on Unique Wealth Strategies's 13F filing for Q4 2025, filed 14 Jul 2026.